GEZIELTE TGF-BETA-HEMMUNG

Patent europeic · EP3889172 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3889172
Numer da la dumonda
EP21165709
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-02-2015
Publitgà
06-10-2021
Concedì
01-05-2024
La protecziun finescha il pli tard
09-02-2035
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07K 14/71 (2006.01)
C07K 16/22 (2006.01)
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
C07K 19/00 (2006.01)
Prioritad
US 201461938048 P 10.02.2014
Derivà da
EP15717097
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 12-03-2025

    Midada

    Published in Swissreg on 12.03.2025

  3. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  4. 04-06-2024

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 04.06.2024

  5. 01-05-2024

    Concedì

    Published in Swissreg on 01.05.2024

Partidas

Possessur

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Represchentant

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventur

LO, Kin-Ming

Lexington, MA 02420, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.